From March 13th to 16th, 2025, the China Medical Equipment Conference and 2025 Medical Equipment Exhibition will be held grandly at the Chongqing International Expo Center. The theme of this conference is "Technology Empowering Industrial Innovation", attracting numerous cutting-edge technological achievements in the field of medical equipment to be showcased. Among them, the 360 ° proton therapy system independently developed by Shanghai Aipuqiang Particle Equipment Co., Ltd. has attracted much attention. As the first proton therapy equipment in China with completely independent intellectual property rights, it not only fills the technological gap in China's high-end proton radiotherapy equipment and breaks the foreign technology monopoly, but also demonstrates China's independent innovation capability and technological breakthroughs in the field of high-end medical devices with excellent performance indicators.

During the exhibition, the popularity of the Aipuqiang booth was high. The proton therapy system showcased has attracted industry attention due to its unique advantages. As an independently developed proton therapy system in our country, not only has its performance indicators reached the international advanced level, but compared with similar imported products, the system is more energy-efficient, has lower radiation, and has less impact on surrounding residents, demonstrating significant advantages. Many industry experts, leaders, investors and other professionals who came to the exhibition stopped to exchange ideas and looked forward to establishing further cooperation with Aipuqiang.

On the morning of March 14th, the Aipuqiang 360 ° Proton Therapy System at the Ruijin Cancer Proton Center affiliated with Shanghai Jiao Tong University School of Medicine was officially launched. The launch ceremony was presided over by Yu Lei, Marketing Director of Aipuqiang. Hou Yan, Chairman of the China Medical Equipment Association, Professor Qiu Jie from Peking Union Medical College Hospital, and Professor Chen Jiayi from Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine were invited to attend and deliver speeches. Experts from more than ten top medical institutions across the country, including Fudan University Affiliated Cancer Hospital and Tianjin Cancer Hospital, gathered at the scene to discuss the clinical application prospects of domestically produced proton therapy equipment.

Chairman Hou Yan pointed out in her speech: "As we all know, proton heavy ion is the highest level of radiotherapy equipment. Today, the Aipuqiang 360 ° proton therapy system was officially launched, which is a major breakthrough in China's precision radiotherapy for tumors and marks that we are also climbing the peak of proton radiotherapy." She emphasized that as a populous country, China also has a huge demand for proton therapy. The successful research and development of this system has built a collaborative innovation model of "industry university research application", driven by clinical demand, adhered to independent innovation, and helped the high-quality development of the domestic medical equipment industry, providing a replicable innovation path for the industrialization of domestic high-end medical equipment. She also hopes that Aipuqiang can continue to research and develop, constantly bring updated and more advanced technologies and equipment, and continue to benefit the vast number of cancer patients.

Professor Qiu Jie from Peking Union Medical College Hospital highly praised Aipuqiang from a clinical perspective: "Aipuqiang has filled the gap in China's high-end proton therapy, and the new 360 ° proton therapy system has freed us from dependence on foreign companies." He particularly pointed out Aipuqiang's outstanding contribution in reducing the cost of proton therapy: "The cost of a single course of treatment has significantly decreased from 270000 yuan for imported equipment to 170000 yuan, approaching the boundary of conventional radiotherapy. Proton therapy is no longer an unattainable technology for the general public, greatly improving the accessibility of high-end radiotherapy for tumors in China and making it affordable for the general public." Professor Qiu Jie has great prospects for the clinical application of Aipuqiang's 360 ° proton therapy system. With great confidence, we hope that Aipuqiang can make proton therapy exclusive to top hospitals Moving towards the standard of universal healthcare.

As the host, Professor Chen Jiayi from Shanghai Ruijin Hospital confirmed the value of the equipment with detailed data and shared valuable experience and practical achievements in using the Aipuqiang proton therapy system. With the use of existing fixed beam and 180 ° treatment systems, the cumulative number of patients treated so far has reached 543, far exceeding expectations. Professor Chen Jiayi also shared treatment cases of pediatric and adolescent cancer patients, fully affirming the stability and accuracy of the Aipuqiang proton therapy system. At present, there is a great demand for proton therapy in clinical practice, and patients have to wait in line for a long time. We believe that after the 360 ° proton therapy system is put into clinical practice, the treatment volume can be further increased and the waiting time for patients can be greatly shortened. "Director Chen said when looking forward to the future, and looks forward to working with Aipuqiang to form a standardized proton therapy" Ruijin Plan "that can be promoted and replicated, and jointly help China's proton therapy take off.

At the end of the ceremony, Chen Zhiling, Vice General Manager of Aipuqiang, gave a comprehensive and in-depth introduction to the Aipuqiang 360 ° Proton Therapy System. The applause from the audience was thunderous, expressing pride in the rise of domestic medical equipment and infinite longing for the future development of medical technology. Many viewers expressed that the emergence of the Aipuqiang 360 ° proton therapy system not only brings new hope to domestic cancer patients, but also marks the emergence of domestic high-end radiotherapy equipment on the international stage, which makes people feel excited and proud. Proton therapy, as an advanced tumor treatment technology, has the characteristics of large device scale, complex technology, and high difficulty in operation, maintenance, and clinical application. At present, the global proton therapy equipment market has long been monopolized by foreign manufacturers, resulting in high equipment and operation costs, opaque technology, and susceptibility to international situations, epidemics, logistics, and other factors, seriously restricting the popularization and application of proton therapy technology in China. The research and application of domestically produced proton therapy equipment is beneficial for shortening project cycles, reducing project risks, and providing more stable, reliable, and economical treatment options for cancer patients in China. As a disruptor in the field of domestic proton therapy, Shanghai Aipuqiang Particle Equipment Co., Ltd. has been deeply involved in the field of proton therapy for more than ten years, always adhering to the corporate mission of "making precision radiotherapy within reach". It has built a complete industrial ecosystem that includes equipment research and development, talent cultivation, and clinical translation. With the official launch of the 360 ° proton therapy system, Aipuqiang will become the only manufacturer with comprehensive proton therapy solutions including fixed beams, 180 ° rotating beams, 360 ° rotating beams, etc. It can customize configuration plans according to hospital needs and perfectly adapt to different clinical application scenarios.

The China Medical Equipment Conference witnesses the rise of domestically produced high-end medical equipment. In the future, Aipuqiang will continue to use technological innovation as an engine to promote tumor radiotherapy from the "precision era" to the "smart era", and provide Chinese solutions for building a high-quality and efficient medical and health service system.